Concepedia

Tilman Schlothauer

TS

Statistics

Publications

40

Citations

2.8K

H-Index

26

Active since

2003

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

University of Oslo

Oslo University Hospital

University of Copenhagen

Tilman Schlothauer is an author at Roche (Switzerland) specializing in biochemistry, pharmacy, and antibody characterization.

Publications per year

2003–2025

40

Publications

40

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer, Sylvia Herter, Claudia Ferrara et al. · Protein Engineering Design and Selection · 2016 · 419 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

Marco Thomann, Tilman Schlothauer, Tetyana Dashivets et al. · PLoS ONE · 2015 · 217 citations · Full text

Life Sciences, Biochemistry, Immunology +17

MecA, an adaptor protein necessary for ClpC chaperone activity

Tilman Schlothauer, Axel Mogk, David A. Dougan et al. · Proceedings of the National Academy of Sciences · 2003 · 168 citations

Life Sciences, Biochemistry, Molecular Biology +17

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans

Hans Peter Grimm, Vanessa Schumacher, Martin Schäfer et al. · mAbs · 2023 · 164 citations · Full text

Pharmacy, Neurology, Neuroscience +17

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies

Markus Haberger, Katrin Bomans, Katharina Diepold et al. · mAbs · 2014 · 162 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +17

1–5 of 40